Suson, Malyn .
HRN: 27-44-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/10/2025
07/11/2025
IV
500mg
Q8
S/p CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes